Detoxification Pathways

Detoxification Pathways Indian Medical PG Question 1: Wrong statement about SGLT (sodium-glucose linked transporter):

• A. SGLT2 inhibitors worsen heart failure (Correct Answer)
• B. SGLT2 inhibitors produce weight loss
• C. SGLT1 is present in the intestine and kidneys
• D. SGLT1 has low capacity and high affinity

Detoxification Pathways Explanation: ***SGLT2 inhibitors worsen heart failure*** - This statement is incorrect because **SGLT2 inhibitors** have been shown to **improve outcomes in heart failure**, reducing hospitalizations and cardiovascular mortality, even in patients without diabetes. - Their beneficial effects in heart failure are attributed to mechanisms such as **osmotic diuresis**, natriuresis, improved cardiac energetics, and reduced preload and afterload. - Landmark trials like **DAPA-HF** and **EMPEROR-Reduced** demonstrated significant benefits in heart failure with reduced ejection fraction (HFrEF). *SGLT2 inhibitors produce weight loss* - **SGLT2 inhibitors** cause **glucosuria** (excretion of glucose in the urine), leading to a loss of calories and subsequent modest weight loss (2-3 kg). - This effect is a common and beneficial side effect, contributing to improved metabolic profiles in patients with type 2 diabetes. *SGLT1 is present in the intestine and kidneys* - **SGLT1** is the primary transporter responsible for glucose absorption in the **small intestine** and is also found in the **kidneys' S3 segment** of the proximal tubule. - In the kidneys, it plays a minor role in glucose reabsorption compared to SGLT2, but it is critical for dietary glucose absorption. *SGLT1 has low capacity and high affinity* - **SGLT1** is characterized by its **high affinity** for glucose (Km ~0.4 mM), allowing it to efficiently reabsorb glucose even at low concentrations. - However, it has a **lower capacity** compared to SGLT2, meaning it reabsorbs a smaller absolute amount of glucose despite its strong binding.

Detoxification Pathways Indian Medical PG Question 2: Which of the following statements represents the most clinically significant aspect of drug metabolism?

• A. Most common enzyme involved is CYP 3A4/5 (Correct Answer)
• B. Glucuronidation is a phase II reaction
• C. Reduction is a phase I reaction
• D. Cytochrome P450 is involved in phase I reactions

Detoxification Pathways Explanation: ***Most common enzyme involved is Cyp 3A4/5*** - CYP3A4/5 is the **most abundant and clinically significant** cytochrome P450 enzyme, responsible for metabolizing approximately **50% of all clinically used drugs**. - Its widespread involvement means variations in its activity (due to **genetics, drug interactions, or disease**) have a major impact on drug efficacy and toxicity. *Glucuronidation is a phase II reaction* - While correct that glucuronidation is a **Phase II metabolic reaction**, this statement describes a biochemical classification rather than a clinically significant aspect compared to the involvement of CYP3A4/5. - Phase II reactions generally involve **conjugation** to increase water solubility and facilitate excretion, but they do not collectively account for as many drug interactions as CYP3A4/5 alone. *Reduction is a phase I reaction* - This statement is factually correct as **reduction** is indeed a **Phase I metabolic reaction**. - However, it represents a generic classification of a metabolic pathway and doesn't highlight the specific clinical importance or prevalence of a particular enzyme or reaction in drug metabolism. *Cytochrome P450 is involved in phase I reactions* - This is true; the **cytochrome P450 system** is the primary enzyme system for **Phase I metabolism**, which introduces or exposes polar groups to make drugs more reactive. - While fundamentally important, this statement is too broad; it does not specify the most clinically significant *aspect* or *enzyme* within the P450 system compared to directly identifying CYP3A4/5.

Detoxification Pathways Indian Medical PG Question 3: Which drug is contraindicated in G6PD deficiency?

• A. Primaquine (Correct Answer)
• B. Chloroquine
• C. Quinine
• D. All of the options

Detoxification Pathways Explanation: ***Primaquine*** - **Primaquine** is an antimalarial drug that generates **severe oxidative stress** in red blood cells. - It is **definitively contraindicated** in **G6PD deficiency** as it consistently causes **acute hemolytic anemia**. - Among antimalarials, primaquine poses the **highest risk** and should **never be used** in G6PD-deficient patients. - It is used for radical cure of P. vivax and P. ovale malaria, but alternative regimens must be used in G6PD deficiency. *Chloroquine* - **Chloroquine** can cause hemolysis in **G6PD deficiency**, though the risk is **lower than primaquine**. - It is **not considered fully safe** and should be used with **caution** in G6PD-deficient patients. - At standard doses, the risk is moderate, but hemolysis can occur, especially in certain G6PD variants. - However, it is not absolutely contraindicated and may be used when benefits outweigh risks with close monitoring. *Quinine* - **Quinine** can also cause **hemolysis** in patients with **G6PD deficiency**. - The risk varies with G6PD variant severity and dosage. - In **severe G6PD deficiency**, quinine should be avoided when alternatives are available. - While less consistently problematic than primaquine, it still requires caution and monitoring. *All of the options* - This option is incorrect in the context of this question because **primaquine** is the **most consistently and severely contraindicated** drug. - While chloroquine and quinine can cause hemolysis, they have **variable risk profiles** and may be used cautiously in some situations, unlike primaquine which is **absolutely contraindicated**. - The question asks for "which drug" (singular), indicating primaquine as the primary answer due to its consistent and severe risk.

Detoxification Pathways Indian Medical PG Question 4: A 75-year-old male on warfarin is prescribed an antibiotic for pneumonia. Which antibiotic requires INR monitoring due to increased bleeding risk?

• A. Ciprofloxacin (Correct Answer)
• B. Amoxicillin
• C. Clindamycin
• D. Azithromycin

Detoxification Pathways Explanation: ***Ciprofloxacin*** - **Ciprofloxacin** and other fluoroquinolones can interact with **warfarin**, though the mechanism is **not well-established** and likely multifactorial (may involve gut flora disruption, protein binding displacement, or metabolic effects). - This interaction can lead to **increased INR** and bleeding risk, requiring close monitoring. - Among fluoroquinolones, the interaction is **less predictable** compared to some other antibiotics. *Amoxicillin* - **Amoxicillin** and other beta-lactam antibiotics can interact with warfarin through **gut flora disruption**, reducing vitamin K synthesis. - This can lead to increased INR, though the effect is generally **mild to moderate**. - Routine INR monitoring is typically sufficient without intensive monitoring. *Clindamycin* - **Clindamycin** has **minimal documented interaction** with warfarin. - It does not significantly affect warfarin metabolism or vitamin K synthesis. - Generally considered a **safer option** for patients on warfarin therapy. *Azithromycin* - **Azithromycin** is well-documented to **significantly increase INR** and bleeding risk in patients on warfarin. - The mechanism may involve **CYP3A4 effects** and other pharmacokinetic interactions. - **FDA warnings exist** regarding this interaction, and close INR monitoring is essential. - Note: While this option is also clinically significant, the question focuses on identifying ONE antibiotic requiring monitoring, with ciprofloxacin being the presented answer in this educational context.

Detoxification Pathways Indian Medical PG Question 5: What is the primary purpose of xenobiotic metabolism?

• A. Increase water solubility (Correct Answer)
• B. Increase lipid solubility
• C. Make them nonpolar
• D. None of the above

Detoxification Pathways Explanation: ***Increase water solubility*** - The primary goal of xenobiotic metabolism is to make these foreign compounds more **hydrophilic** (water-soluble). - This increased water solubility facilitates their **excretion** from the body via urine or bile. *Increase lipid solubility* - Increasing **lipid solubility** would make xenobiotics more likely to accumulate in **adipose tissue** and pass through cell membranes, hindering their excretion. - This is the opposite of the desired outcome for xenobiotic elimination. *Make them nonpolar* - Making xenobiotics **nonpolar** would be equivalent to increasing their lipid solubility, as nonpolar molecules tend to be lipid-soluble. - This would impede excretion and potentially lead to **bioaccumulation**, which is harmful. *None of the options* - This option is incorrect because xenobiotic metabolism specifically aims to increase **water solubility** for elimination.

Detoxification Pathways Flashcard 1 of 5

Question: Carcinoid tumors often secrete _____, which is dumped into the portal vein and processed by the liver via monoamine oxidase (MAO)

Answer: serotonin (5-HT)

Detoxification Pathways Flashcard 2 of 5

Question: Ferroptosis is triggered when there are low levels of _____.

Answer: reduced glutathione

Detoxification Pathways Flashcard 3 of 5

Question: Which is the rate-limiting step for the entire process of hepatic bilirubin metabolism?_____

Answer: Secretion of conjugated bilirubin

Detoxification Pathways Flashcard 4 of 5

Question: Cytochrome p450 is a _____-oxygenase

Answer: mono (di/mono)

Detoxification Pathways Flashcard 5 of 5

Question: In liver _____, ethanol may be converted to acetaldehyde via the enzyme CYP2E1

Answer: microsomes